Quarterly report [Sections 13 or 15(d)]

SEGMENT INFORMATION (Tables)

v3.25.3
SEGMENT INFORMATION (Tables)
9 Months Ended
Sep. 30, 2025
SEGMENT INFORMATION  
Schedule of segment information

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended September 30, 

​

Nine Months Ended September 30, 

​

​

2025

​

2024

 

2025

​

2024

​

​

(in thousands)

​

(in thousands)

Total Revenues

​

$

69,462

​

$

55,307

​

$

224,480

​

$

121,682

Less:

​

​

​

​

​

​

​

​

​

​

​

​

Employee related expenses

​

​

18,547

​

​

16,104

​

​

56,666

​

​

52,552

Commercial related expenses

​

​

6,303

​

​

6,768

​

​

18,915

​

​

19,002

Outside clinical trial related expenses

​

​

3,759

​

​

3,303

​

​

11,362

​

​

8,183

Cost of product sales

​

​

4,753

​

​

8,026

​

​

13,666

​

​

12,859

Consultants and third-party services

​

​

4,133

​

​

3,476

​

​

10,751

​

​

11,851

Other segment items

​

​

3,547

​

​

3,574

​

​

10,824

​

​

9,698

Interest expense, net

​

​

800

​

​

1,635

​

​

3,183

​

​

4,393

(Benefit from) provision for income taxes

​

​

(280)

​

​

—

​

​

154

​

​

—

Segment income

​

$

27,900

​

$

12,421

​

$

98,959

​

$

3,144